Efficacy of traditional Japanese herbal medicines-keishikajutsubuto (TJ-18) and bushi-matsu (TJ-3022)-against postherpetic neuralgia aggravated by self-reported cold stimulation: A case series

Journal of Alternative and Complementary Medicine

Volumn 18, Issue 7, 2012, Pages 686-692

  Nakanishi, Miho ^a   Arimitsu, Junsuke ^a   Kageyama, Mitsuru ^b   Otsuka, Shizue ^a   Inoue, Takaya ^a   Nishida, Shinji ^a   Yoshikawa, Hideki ^c   Kishida, Yuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kageyama Clinic   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSHI MATSU; HERBACEOUS AGENT; KEISHIKAJUTSUBUTO; TJ 18; TJ 3022; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD EXPOSURE; COMBINATION CHEMOTHERAPY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HOT FLUSH; HUMAN; MALE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SELF REPORT; STOMACH DISCOMFORT; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALGESICS; ANGIOSPERMS; COLD TEMPERATURE; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HERPES ZOSTER; HUMANS; JAPAN; MALE; MEDICINE, KAMPO; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; PHYTOTHERAPY; PLANTS, MEDICINAL; TREATMENT OUTCOME;

EID: 84864370055     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2010.0745     Document Type: Article

References (40)

1. Head H, Campbell AW, Kennedy PG. The pathology of Herpes Zoster and its bearing on sensory localisation. Rev Med Virol 1997;7:131-143. (Pubitemid 127780269)
2. Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. NEJM 2002;347:340-346.
3. Hope-Simpson RE. The nature of Herpes Zoster: A longterm study and a new hypothesis. Proc R Soc Med 1965;58:9-20.
4. Weller TH. Varicella and herpes zoster: Changing concepts of the natural history, control, and importance of a notso-benign virus. NEJM 1983;309:1434-1440. (Pubitemid 14245140)
5. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996;67:241-251. (Pubitemid 26375339)
6. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract 1975;25:571-575.
7. Kost RG, Straus SE. Postherpetic neuralgia: Pathogenesis, treatment, and prevention. NEJM 1996;335:32-42. (Pubitemid 26230812)
8. Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-1349. (Pubitemid 350060129)
9. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis 1998;5:209-227. (Pubitemid 28519152)
10. Dubinsky RM, Kabbani H, El-Chami Z, et al. Practice parameter: Treatment of postherpetic neuralgia: An evidencebased report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;63: 959-965. (Pubitemid 39287901)
11. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain: Consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007;12:13-21. (Pubitemid 46744774)
12. Dworkin RH, Corbin AE, Young JP Jr, et al. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003;60:1274-1283. (Pubitemid 36460982)
13. Attal N, Cruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006;13:1153-1169. (Pubitemid 44581463)
14. Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment response in antidepressant-naive postherpetic neuralgia patients: Double-blind, randomized trial. J Pain 2005;6: 741-746. (Pubitemid 41579071)
15. Gore M, Sadosky A, Tai KS, Stacey B. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. Clin Ther 2007;29:1655-1670. (Pubitemid 47500130)
16. Cappuzzo KA. Treatment of postherpetic neuralgia: Focus on pregabalin. Clin Interv Aging 2009;4:17-23.
17. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524-1534. (Pubitemid 37443116)
18. Jorum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: The effect of N-methyl-Daspartate (NMDA) receptor antagonist ketamine. A doubleblind, cross-over comparison with alfentanil and placebo. Pain 2003;101:229-235. (Pubitemid 36173763)
19. Rowbotham MC, Fields HL. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 1996;119(pt 2):347-354. (Pubitemid 26149354)
20. Gagnier JJ, Boon H, Rochon P, et al. Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement. Ann Intern Med 2006;144:364-367. (Pubitemid 46768190)
21. Sabatowski R, Galvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain 2004;109:26-35. (Pubitemid 38479767)
22. Van Seventer R, Feister HA, Young JP Jr, et al. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial. Curr Med Res Opin 2006;22:375-384. (Pubitemid 44296762)
23. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001;94:215-224. (Pubitemid 33016615)
24. Ameri A. Effects of the Aconitum alkaloid mesaconitine in rat hippocampal slices and the involvement of alpha- and betaadrenoceptors. Br J Pharmacol 1998;123:243-250. (Pubitemid 28039550)
25. Murayama M, Mori T, Bando H, Amiya T. Studies on the constituents of Aconitum species: IX. The pharmacological properties of pyro-type aconitine alkaloids, components of processed aconite powder kako-bushi-matsu: Analgesic, antiinflammatory and acute toxic activities. J Ethnopharmacol 1991;35:159-164.
26. Murayama M, Namiki Y. Pharmacological study of kakobushi-matsu: Analgesic action and acute toxicity [in Japanese]. Nippon Yakurigaku Zasshi 1989;94:309-317. (Pubitemid 19270359)
27. Isono T, Oyama T, Asami A, et al. The analgesic mechanism of processed Aconiti tuber: The involvement of descending inhibitory system. Am J Chin Med 1994;22:83-94.
28. Omiya Y, Goto K, Suzuki Y, et al. Analgesia-producing mechanism of processed Aconiti tuber: Role of dynorphin, an endogenous kappa-opioid ligand, in the rodent spinal cord. Jpn J Pharmacol 1999;79:295-301. (Pubitemid 29168139)
29. Xu H, Arita H, Hayashida M, et al. Pain-relieving effects of processed Aconiti tuber in CCI-neuropathic rats. J Ethnopharmacol 2006;103:392-397. (Pubitemid 43143375)
30. Shu H, Arita H, Hayashida M, et al. Inhibition of morphine tolerance by processed Aconiti tuber is mediated by kappaopioid receptors. J Ethnopharmacol 2006;106:263-271. (Pubitemid 43766191)
31. Makino T, Kato K, Mizukami H. Processed aconite root prevents cold-stress-induced hypothermia and immunosuppression in mice. Biol Pharm Bull 2009;32:1741-1748.
32. Uchida REY. Effectiveness of Aconiti tuber for pain. Clin J Trad Chin Med 2003;24:366-373.
33. Nagasaka KT, Natori M, Hiroaki H. Study of Shuchi-Bushi, a powder type of Aconiti tuber after being autoclaved, especially concerning side effects: Usage and dosage of Shuchi-Bushi from this study. Kampo Med 2005;56:797-800.
34. Sato HYC, Konno C, Ohizumi Y, et al. Pharmacological actions of aconitine alkaloids. Tohoku J Exp Med 1979;128: 175-187. (Pubitemid 9217070)
35. Satoh K, Takano S, Kobayashi T. Keishikajutsubuto (Guizhi-shufu-tang) treatment for refractory accumulation of synovial fluid in a patient with pustulotic arthro-osteitis. Fukushima J Med Sci 2007;53:33-38.
36. Zhang XJ, Li Z, Leung WM, et al. The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats. J Pain 2008;9:497-505.
37. Yu HY, Liu MG, Liu DN, et al. Antinociceptive effects of systemic paeoniflorin on bee venom-induced various phenotypes of nociception and hypersensitivity. Pharmacol Biochem Behav 2007;88:131-140.
38. Drake TE, Maibach HI. Allergic contact dermatitis and stomatitis caused by a cinnamic aldehyde-flavored toothpaste. Arch Dermatol 1976;112:202-203.
39. Nixon R. Cinnamon allergy in a baker. Australas J Dermatol 1995;36:41.
40. Calnan CD. Cinnamon dermatitis from an ointment. Contact Dermatitis 1976;2:167-170.